INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
74 hedge funds and large institutions have $53.7M invested in Infinity Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
57% less capital invested
Capital invested by funds: $125M → $53.7M (-$70.9M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
74
Holding in Top 10
–
Calls
$259K
Puts
$71K
Top Buyers
| 1 | +$1.16M | |
| 2 | +$835K | |
| 3 | +$526K | |
| 4 |
D.E. Shaw & Co
New York
|
+$360K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$349K |
Top Sellers
| 1 | -$6.36M | |
| 2 | -$3.28M | |
| 3 | -$1.17M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$730K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$691K |